Results of a phase II study of bendamustine and ofatumumab in untreated indolent B cell non-Hodgkin's lymphoma.
Auteurs : Czuczman MS, Kahanic S, Forero A, Davis G, Munteanu M, Van Den Neste E, Offner F, Bron D, Quick D, Fowler N
Jaar : 2015
Journal : Ann Hematol
Volume : 94(4)
Pagina's : 633-41